A STUDY ON THE WORKING CAPITAL MANAGEMENT AT ANUS LABS

Registered Office of the Company

A-49, Madura Nagar, Vengalrao Nagar, Hyderabad 500 038 Phone: +9963525176, 9701087492 Fax: +91 40 23741674 E mail: ipo@anulabs.com Website: www.anulabs.com

INDUSTRY PROFILE

After the introduction of new patent policy in 2005, Indian pharmaceutical industry rapidly growing . Domestic pharmaceutical companies are penetrating in to international market and when ever there are chances Indian pharmaceutical companies take-covering, purchasing several other countries companies.

This trend is going to increasing. Major companies increasing their expenditure on Research & Development (R&D) . Contract research and Parma testing activities are also growing in Indian market. By identifying these trends several multinational companies are establishing their centers in India.

IN ANDHRA PRADESH

Andhra Pradesh stands first in Parma industry in India. Several Andhra Pradesh based companies are competing with MNC's in this sector. Our medicines have good prepotency in American market and European market also. Our companies are producing very much qualitative medicine to cure such above said I diseases.

FACTORS
1. 2. 3. 4 5. 6. 7. 8.

Low cost labor and Infrastructure. High level of technology availability. Technologically capable Human resources. Liberal Govt. policies. Strong market base. Good relations with entire world. Fast growing and adoptability. Efficient target market and others.

INVESTMENTS ON R&D IN INDIAN PHARMA INDUSTRY:

In 1983-84 money expensed on R&D was Rs.40 corers. This is further increased to Rs.370 corers in 2001-02.

In 2007-08 annual allotments for R&D in Indian Parma industry was Rs.1686 corers, it was increased to Rs.1956 corers in 2010-2011.

COMPANY PROFILE

Logo:

GENERAL INFORMATION

Our Company was incorporated as Anus Laboratories Limited on February 20, 1996 and got the Certificate of Commencement of Business Certificate on March 6, 1996.

HISTORY
Anu's Laboratories Ltd. is an ISO 9001:2000 certified company, established in 1996 and engaged in manufacture of quality drug intermediates to meet the needs of international customers. The state-of-art R&D facilities are located at ICICI knowledge park, Hyderabad and support the process development, contract research and custom synthesis programmers of the organization.

VISION

Manufacture and supply of superior quality, cost effective intermediates for APIs. High focus on R&D to develop complex organic molecules and extend support to synthesis of new chemical entities.

CORPORATE VISION
ANU'S want to be one of the leaders in the PHARMACEUTICAL industry, with all India presence, through. High quality products and brand image. Modem, cost effective and energy efficient manufacturing facility. Sustained growth in profitability. High level of satisfaction to all stakeholders.

STRENGTHS OF ANUS
Good manpower productivity and industrial relations. Low capital cost hence cost of production is low. Excellent maintenance practices and timely planned replacement decreasing down time in plant. Reliable supply of raw materials, long time contract with suppliers for supply of raw materials.

Well located in respect of raw materials and market. Adequate storage at factory. Company enjoys a good brand image and value. A strong team of 30 chemists undertake R&D activities following GLP. The major areas of our R&D focus is: To develop technologies for new products To establish processes in laboratory for products to be scaled u

PRINCIPLES OF ANUS

To propagate and adhere the group values and beliefs.

To achieve cost effective operations through profitable funds management and efficient financial control.

To create cost and quality consciousness at all levels.

To increase levels of employee motivation, commitment and sense of belonging. To strictly adhere to all statutory norms on environmental protection, pollution control and ensure total safety to employees and neighborhood.

To use information technology as a, strategic tool for management.

SCOPE OF THE STUDY

The scope of my study is constitutes to be one of the interesting and key areas of working capital management. The study concentrates on the financial status or affairs of the company and the management of working capital in the company which involves the study of operating cycle and ratios of different periods and their comparison over the last three years. It helps to present broader picture of the financial position of the company.

OBJECTIVES OF THE STUDY

1. To study the existing system of working capital management in ANUS LABORATORIES and to examine the relation between various components of working capital.

2. To evaluate the working capital requirement of the company. 3. To make comparisons between the ratios during different periods.

4. To offer suggestions, if any. For the better financial performance of the company. 5. To analyses the efficiency in use of working capital 6. To the efficiency of the company in utilizing in current assets

NEED FOR THE STUDY

1. for the purchases of raw materials, components and spares 2. To pay wages and salaries

3. To incur day to day expenses and over head costs such as fuel, power and office expenses etc..
4. To meet the setting cost as packing advertising etc.. 5. To provide credit facilities to the customers

LIMITATIONS OF THE STUDY

The present study is done with sincerity and earnestness it has its share of limitations. By calculating various ratios we can know the firm's position better and can compare with other firms. It is also a major constraint. The study is based on the present situation and only change in the firms operations may affect the results and finding of the study. Limited time is a limitation to get the entire information.